Earnings · China A-shares
Jafron Biomedical Co., Ltd. Class A (300529) earnings
Jafron Biomedical Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit +26.79% year on year, +23.63% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +15.62% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- +26.79%
- Excl. one-offs YoY
- +23.63%
- Net profit QoQ
- +19.34%
- Result
- Good
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +9.15% | — |
| 3 days | +15.62% | — |
| 7 days | +32.61% | — |
| 14 days | +32.16% | — |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 3 of 6 reports (average +0.09%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | ¥574.65M | +26.79% | +23.63% | +3.50% | 0.74 | 16.02% | +15.62% | — | — |
| 2026 interim report | 2026-08-07 | ¥381.97M | -1.99% | -4.71% | -8.99% | 0.49 | 10.60% | -8.14% | -15.66% | -12.05% |
| 2026 Q1 report | 2026-04-28 | ¥220.51M | +16.81% | +13.14% | +2.33% | 0.28 | 6.15% | +4.85% | -9.14% | -8.52% |
| 2025 annual report | 2026-04-28 | ¥532.82M | -35.04% | -34.16% | -24.86% | 0.69 | 15.91% | +4.85% | -9.14% | -8.52% |
| 2025 Q3 report | 2025-10-30 | ¥453.23M | -42.75% | -41.87% | -29.13% | 0.59 | 13.74% | -6.01% | -6.80% | -2.05% |
| 2025 interim report | 2025-08-22 | ¥389.72M | -29.46% | -29.08% | -24.15% | 0.51 | 11.35% | +2.37% | -6.64% | -14.43% |
| 2025 Q1 report | 2025-04-16 | ¥188.78M | -33.71% | -32.15% | -26.40% | 0.23 | 5.50% | -8.16% | -10.50% | -13.20% |
| 2024 annual report | 2025-04-16 | ¥820.20M | +87.91% | +90.46% | +39.27% | 1.05 | 26.43% | -8.16% | -10.50% | -13.20% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.